Pure Global
NCT06414824

The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes

The Impact of the isCGM Use on the Hypoglycemic Episodes and Fear of Hypoglycemia in Patients With Newly Diagnosed Type 1 Diabetes
Jagiellonian University·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus, Type 1
Drug/Device/Intervention
Intermittently Scanned Continuous Glucose Monitoring
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Jagiellonian University
Location
Bialystok,Krakow,Poznan,Zabrze, Poland
Timeline & enrollment
Phase
N/A
Start date
May 01, 2022
End date
Dec 01, 2024
Enrollment
100 participants
Primary outcome

Hypoglycemia Fear Survey II,TBR 70 mg/dL

Summary

The aim of this trial is to investigate the impact of FreeStyle Libre use compared to SMBG on
 hypoglycemia episodes and fear of hypoglycemia in adults aged 18-35 with newly diagnosed type
 1 diabetes.
 
 This trial is conducted in university centers in Poland (Bialystok, Krakow, Poznan, Zabrze).

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06414824
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06414824 through Pure Global AI's free database. This phase not specified trial is sponsored by Jagiellonian University and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.